Clinical Trial Update: Folic Acid for Prevention of Contrast Induced Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating folic acid for prevention of contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• folic acid (folic acid)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Kidney Diseases, Urologic Diseases | Phase 4 | Status: UNKNOWN